How 4Life Research found transfer factor in a field crop.

PhytoFactor™ is the first plant-based source of transfer factor ever commercialized, developed by 4Life Research USA, LLC and extracted from the seeds of Brassica napus — the flowering Brassicaceae crop known as rapeseed, and the plant pressed to make canola oil. Its discovery in the early 2020s ended a seventy-five-year assumption that transfer factor could only be sourced from animals, and it is the reason 4Life Transfer Factor® Max exists in the form it does.

This article is the origin story: the seventy-five years of animal-only sourcing that preceded it, the reasoning that pointed a research team toward plants, why Brassica napus turned out to be the right plant, and what the finding changed. If you are looking for a plain definition of the ingredient and where to get it, our companion guide — What is PhytoFactor™? — is the better starting point. This one is about how it got here.

The seventy-five-year assumption

To understand why finding transfer factor in a plant was surprising, you have to understand why nobody was looking.

1949 — Lawrence isolates something that shouldn't work

At New York University School of Medicine, immunologist H. Sherwood Lawrence was studying tuberculin sensitivity. He took white blood cells from a donor who had been exposed to tuberculosis, broke the cells apart, filtered out everything large enough to be a cell or an antibody, and injected the remaining extract into a person who had never been exposed.

The recipient's immune system began responding to tuberculin as though it had encountered the pathogen before. Something in the filtrate — far too small to be an antibody, far too small to be a cell — had carried immunological information from one person to another. Lawrence called it transfer factor, because that is precisely what it did: it transferred the factor of immunity.

The discovery was foundational, and it also set the frame that would hold for three generations. Transfer factor came from immune cells. Immune cells came from animals. Therefore transfer factor came from animals. That syllogism was never seriously questioned, because it did not look like an assumption. It looked like a definition.

1998 — 4Life moves the source from blood to milk

Lawrence's transfer factor was scientifically extraordinary and commercially impossible. Sourcing it from human white blood cells does not scale, and it never could.

David and Bianca Lisonbee founded 4Life Research in Sandy, Utah in 1998 around the insight that solved this: transfer factor is not exclusive to blood. A mother passes immune information to her newborn through colostrum, the antibody-rich first milk. Bovine colostrum contains the same class of transfer factor peptides — and unlike human white blood cells, it is a renewable agricultural product available at scale.

That move built an industry. 4Life became known as The Immune System Company, and its extraction of transfer factor from colostrum — later branded UltraFactor XF® — is the foundation everything since has been built on.

The 2000s and 2010s — widening the animal kingdom

The next two decades extended the source set, but never left the frame. OvoFactor® brought transfer factor from hen egg yolk — a second animal source with a different transfer profile. NanoFactor® isolated a nanofiltered fraction of colostrum concentrating the smaller immune-modulating molecules. Combined, the three became the Tri-Factor® Formula: cow, hen, and the nanofraction.

Three sources. Two species. Both animals. The frame was still holding — and by every commercial measure, it was working fine.

The question nobody asked

Somewhere in the early 2020s, 4Life Research's scientists put a question on the table that sounds naive until you sit with it: why do we believe only animals make these peptides?

The intuitive answer is that transfer factor is immune-system machinery, and plants have no immune system in the mammalian sense. No T cells. No B cells. No neutrophils. No thymus. No bone marrow. Nothing that resembles the architecture Lawrence was studying in 1949.

But that answer conflates two different things — having an immune system and producing defense peptides. Plants are attacked constantly by fungi, bacteria, viruses, and insects, and they have never had the option of retreating. What they evolved instead is a chemical defense apparatus of remarkable sophistication, including large families of small bioactive peptides used to detect threats and coordinate responses across plant tissue.

Put that way, the question inverts. It stops being why would a plant have immune-messenger peptides? and becomes why would seventy-five years of researchers have assumed it couldn't? The honest answer is the ordinary one: because the first place anyone found transfer factor was inside an immune system, and nobody went back to check whether that was the only place it lived.

Why Brassica napus

Screening plant material for transfer factor activity is not a matter of intuition — it is a matter of testing, and most of what gets tested does not work. Activity did not turn up everywhere. It turned up in the seeds of one species in the cabbage family.

Brassica napus is not exotic. It is one of the most widely cultivated crops on Earth: the bright-yellow bloom that rolls across European and North American farm country each spring, grown at enormous scale and pressed into canola oil, the world's third-largest source of vegetable oil. If you were writing this as fiction, you would have chosen a rare orchid from a cloud forest. Reality chose a commodity crop.

Three properties made it the right find rather than merely an interesting one:

• The activity is in the seed. Not the leaf, not the stem, not the flower — the seed, which is where a plant concentrates what it needs to protect its next generation. Biologically, that is a sensible place for defense peptides to be.
• The safety record already existed. Billions of people have consumed Brassica napus in the form of canola oil for decades. A novel ingredient from a plant nobody has ever eaten carries a very different burden of proof than one from a plant already on the world's dinner table.
• The supply chain was already built. Global rapeseed acreage runs to tens of millions of hectares. There was no need to establish cultivation for a plant that half the world already farms — the raw material was a purchase order, not a fifteen-year agronomy program.

The extraction itself is where the real proprietary work sits. PhytoFactor is not canola oil, and the difference matters: canola is the cold-pressed lipid fraction of the seed, while PhytoFactor is the protein-and-peptide fraction isolated through 4Life Research's own process. Same seed, different fraction, entirely different ingredient — the way wheat germ oil and wheat flour share an origin and share nothing else.

What they found: two mechanisms, not one

The result that shaped the product was not simply that plant transfer factor worked. It was that it appeared to work in two ways.

In 4Life Research's preclinical studies, PhytoFactor demonstrated the messenger activity that defines the category — helping immune cells recognize threats and coordinate a response, the same job UltraFactor XF® and OvoFactor® have always done. But it also showed a more direct effect on invading organisms themselves.*

That is the whole hinge of the story. If PhytoFactor had merely replicated what colostrum already did, the sensible move would have been a plant-based alternative product — same benefit, vegan-friendly, done. Instead the finding was additive: a second mechanism sitting alongside the first rather than substituting for it.

Which is why 4Life did the counterintuitive thing and combined them.

The timeline, end to end

What is documented, and what isn't

A discovery story invites embellishment, so it is worth being precise about the edges of the record.

Documented: Lawrence's 1949 discovery is peer-reviewed immunological history. 4Life Research's founding in 1998 by David and Bianca Lisonbee is a matter of public corporate record. The composition of Transfer Factor Max — 900 mg total, 600 mg Tri-Factor, 300 mg PhytoFactor, from Brassica napus — is published by the manufacturer. Yu et al. (2024) is peer-reviewed and public.

Not public: 4Life has not released a laboratory-notebook account of the discovery — no named lead scientist, no dated eureka moment, no published screening protocol. The proprietary extraction process is, by design, proprietary. Anyone telling you a more cinematic version of this story than the one above, with named characters and a specific afternoon in a specific lab, is filling gaps that 4Life has not filled.

We would rather hand you an accurate story with edges than a vivid one without them. The verifiable core is remarkable enough: a seventy-five-year assumption was tested, it turned out to be narrower than everyone believed, and the resulting ingredient is now in a product you can buy.

Why the discovery mattered

Three consequences follow from PhytoFactor, and only one of them is about the product.

The first is access. Transfer factor had never been available to anyone avoiding animal products. PhytoFactor is the first version that is — which is why 4Life Super Greens and Immune Tea, both built on PhytoFactor without animal-derived transfer factor, exist as their own products rather than as compromises.

The second is mechanism. A formula combining two complementary mechanisms is a different proposition from one relying on a single hero ingredient. Max is a multi-mechanism formula by construction, not by marketing.

The third is the one worth sitting with: the category's foundational assumption was wrong, and it took seventy-five years to check. That is not a criticism of anyone. It is how science actually works — a frame holds until someone tests its edge. It also raises an obvious question that 4Life's own finding poses: if transfer factor is in this plant, what else is it in?

Nobody has answered that yet. But for the first time since 1949, it is a reasonable question to ask.

Frequently Asked Questions

Citations & sources

Keep reading

*These statements have not been evaluated by the Food and Drug Administration. PhytoFactor and Transfer Factor Max are dietary-supplement ingredients and products and are not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Consult your healthcare provider before beginning any new supplement program.